<p>，/PRNewswire/ -- Azra AI 是一家醫療企業平台，通過先進的人工智能和自動化技術，正在轉變癌症護理協調和臨牀路徑的編排，今天宣佈任命 Jessica Turgon 為其董事會成員。</p>
<p>Turgon 是一位全國公認的腫瘤戰略家和醫療高管，擁有數十年的經驗，曾為領先的醫療系統、癌症中心和醫療組織提供有關腫瘤增長、運營轉型和護理交付創新的諮詢。她曾擔任西門子醫療的全球腫瘤服務線負責人，並在 ECG 管理顧問公司工作了 20 年，領導全國範圍內的腫瘤諮詢項目。</p>
<p>她的任命正值醫療系統日益尋求可擴展的人工智能驅動解決方案，以改善癌症篩查、護理協調、運營效率和患者結果，同時應對日益增長的臨牀和人力資源壓力。</p>
<p>“Jessica 在醫療保健的關鍵時刻帶來了卓越的腫瘤專業知識、醫療系統戰略和運營洞察，” Azra AI 的首席執行官 John Marshall 表示。“她在幫助醫療系統應對複雜性和建立更強大的腫瘤項目以改善患者護理方面度過了她的職業生涯。隨着 Azra 在腫瘤運營中繼續擴大人工智能的應用，Jessica 的視角和領導力將對我們加速使命和擴大影響力至關重要。”</p>
<p>在她的職業生涯中，Turgon 曾為醫療組織提供有關癌症服務線戰略、患者獲取、護理交付優化、醫生對齊和企業轉型項目的諮詢。她因對腫瘤項目面臨的運營和臨牀挑戰的深刻理解而廣受認可，並幫助組織現代化護理模式，以更好地服務患者。</p>
<p>在西門子醫療，Turgon 領導全球腫瘤戰略工作，專注於推進綜合癌症護理和通過創新及技術驅動的轉型改善結果。在 ECG 任職期間，她因幫助醫院和醫療系統加強腫瘤運營而聞名，同時始終關注患者體驗。</p>
<p>“Azra AI 正在解決當今醫療保健中最重要的挑戰之一：幫助醫療系統將分散的數據轉化為協調的、可操作的護理，形成一個完整的端到端平台。” Turgon 説。“該公司將人工智能操作化的能力直接支持腫瘤團隊，加速患者識別和治療，並改善護理連續性，令人信服。我很高興能加入董事會，支持 Azra 的持續增長和使命。”</p>
<p>Azra AI 的企業平台將未充分利用的醫療數據操作化，以優化和編排護理和臨牀試驗路徑——確保患者在其醫療系統內獲得及時、協調的護理，提高患者保留率和結果，並通過可操作的實時報告使患者護理可見。</p>
<p>通過結合先進的代理人工智能、多模態數據集成和工作流程自動化，Azra 將分散的臨牀數據轉化為可操作的智能——為肺癌和乳腺癌篩查、偶發發現、多學科會議、企業患者管理和護理協調、研究和臨牀試驗匹配、急診出院工作流程以及高級報告和分析提供解決方案。</p>
<p>該平台在單一生態系統內統一這些能力，使醫療系統能夠更早識別患者，縱向協調護理，並消除整個連續性中的空白。Azra AI 在數百個領先的醫療系統中部署，幫助減少治療時間，同時推動患者結果、運營效率和規模化投資回報的可衡量改善。</p>
<p><strong>關於 Azra AI</strong></p>
<p>Azra AI 是一家醫療企業平台，將未充分利用的數據操作化，以優化和編排護理和臨牀試驗路徑——確保患者在其醫療系統內獲得及時、協調的護理，提高患者保留率和結果，並通過可操作的實時報告使患者護理可見。</p>
<p>通過結合先進的代理人工智能、多模態數據集成和工作流程自動化，Azra 將分散的臨牀數據轉化為可操作的智能——為肺癌和乳腺癌篩查、所有偶發發現、多學科會議、企業患者管理/護理協調、研究/臨牀試驗匹配、急診出院和強大的報告與分析提供解決方案。</p>
<p>Azra 在單一平台內統一這些能力，使醫療系統能夠更早識別患者，縱向協調護理，並消除整個連續性中的空白。Azra 的平台在數百個領先的醫療系統中部署，減少治療時間，從而在患者結果、運營效率和規模化投資回報方面帶來可衡量的改善。</p>
<p>瞭解更多信息，請訪問 www.azra-ai.com。</p>
<p>媒體聯繫人：</p>
<p>John Marshall</p>
<p>[email protected]</p>
<p>來源：Azra AI</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTE5Jk5ld3NJdGVtSWQ9Q0w2MjExNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTkwOTAzUFJfTkVXU19VU1BSX19fX19DTDYyMTE3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTE5Jk5ld3NJdGVtSWQ9Q0w2MjExNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTkwOTAzUFJfTkVXU19VU1BSX19fX19DTDYyMTE3"/></p>

<p>Azra AI 已任命公認的腫瘤戰略家傑西卡·圖爾貢（Jessica Turgon）為其董事會成員。圖爾貢在腫瘤增長和運營轉型方面擁有豐富的經驗，曾在西門子醫療（Siemens Healthineers）和 ECG 管理顧問公司工作。她的專業知識將支持 Azra AI 的使命，通過人工智能驅動的解決方案提升癌症護理協調，解決當今醫療保健中的關鍵挑戰</p>

<p>, /PRNewswire/ -- Azra AI, the healthcare enterprise platform transforming cancer care coordination and clinical pathway orchestration through advanced AI and automation, today announced the appointment of Jessica Turgon to its Board of Directors.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Azra AI 是一家醫療企業平台，通過先進的人工智能和自動化技術，正在轉變癌症護理協調和臨牀路徑的編排，今天宣佈任命 Jessica Turgon 為其董事會成員。</p>
</div><p>Turgon is a nationally recognized oncology strategist and healthcare executive with decades of experience advising leading health systems, cancer centers, and healthcare organizations on oncology growth, operational transformation, and care delivery innovation. She has previously worked roles as Global Service Line Head for Oncology a Siemens Healthineers and spent 20 years at ECG Management Consultants, where she led oncology consulting initiatives for health systems across the country.</p>
<div class="lb-trans"><p>Turgon 是一位全國公認的腫瘤戰略家和醫療高管，擁有數十年的經驗，曾為領先的醫療系統、癌症中心和醫療組織提供有關腫瘤增長、運營轉型和護理交付創新的諮詢。她曾擔任西門子醫療的全球腫瘤服務線負責人，並在 ECG 管理顧問公司工作了 20 年，領導全國範圍內的腫瘤諮詢項目。</p>
</div><p>Her appointment comes as health systems increasingly seek scalable AI-driven solutions to improve cancer screening, care coordination, operational efficiency, and patient outcomes amid growing clinical and workforce pressures.</p>
<div class="lb-trans"><p>她的任命正值醫療系統日益尋求可擴展的人工智能驅動解決方案，以改善癌症篩查、護理協調、運營效率和患者結果，同時應對日益增長的臨牀和人力資源壓力。</p>
</div><p>&#34;Jessica brings an extraordinary combination of oncology expertise, health system strategy, and operational insight at a pivotal moment for healthcare,&#34; said John Marshall, CEO of Azra AI. &#34;She has spent her career helping health systems navigate complexity and build stronger oncology programs that improve patient care. As Azra continues scaling AI adoption across oncology operations, Jessica's perspective and leadership will be invaluable in helping us accelerate our mission and expand our impact.&#34;</p>
<div class="lb-trans"><p>“Jessica 在醫療保健的關鍵時刻帶來了卓越的腫瘤專業知識、醫療系統戰略和運營洞察，” Azra AI 的首席執行官 John Marshall 表示。“她在幫助醫療系統應對複雜性和建立更強大的腫瘤項目以改善患者護理方面度過了她的職業生涯。隨着 Azra 在腫瘤運營中繼續擴大人工智能的應用，Jessica 的視角和領導力將對我們加速使命和擴大影響力至關重要。”</p>
</div><p>Throughout her career, Turgon has advised healthcare organizations on cancer service line strategy, patient access, care delivery optimization, physician alignment, and enterprise transformation initiatives. She is widely recognized for her deep understanding of the operational and clinical challenges facing oncology programs and for helping organizations modernize care models to better serve patients.</p>
<div class="lb-trans"><p>在她的職業生涯中，Turgon 曾為醫療組織提供有關癌症服務線戰略、患者獲取、護理交付優化、醫生對齊和企業轉型項目的諮詢。她因對腫瘤項目面臨的運營和臨牀挑戰的深刻理解而廣受認可，並幫助組織現代化護理模式，以更好地服務患者。</p>
</div><p>At Siemens Healthineers, Turgon lead global oncology strategy efforts focused on advancing integrated cancer care and improving outcomes through innovation and technology-enabled transformation. During her tenure at ECG, she became known for her work helping hospitals and health systems strengthen oncology operations while maintaining a strong focus on the patient experience.</p>
<div class="lb-trans"><p>在西門子醫療，Turgon 領導全球腫瘤戰略工作，專注於推進綜合癌症護理和通過創新及技術驅動的轉型改善結果。在 ECG 任職期間，她因幫助醫院和醫療系統加強腫瘤運營而聞名，同時始終關注患者體驗。</p>
</div><p>&#34;Azra AI is addressing one of the most important challenges in healthcare today: helping health systems turn fragmented data into coordinated, actionable care in a single end-to-end platform.&#34; said Turgon. &#34;The company's ability to operationalize AI in a way that directly supports oncology teams, accelerates patient identification and treatment, and improves continuity of care is incredibly compelling. I'm excited to join the Board and support Azra's continued growth and mission.&#34;</p>
<div class="lb-trans"><p>“Azra AI 正在解決當今醫療保健中最重要的挑戰之一：幫助醫療系統將分散的數據轉化為協調的、可操作的護理，形成一個完整的端到端平台。” Turgon 説。“該公司將人工智能操作化的能力直接支持腫瘤團隊，加速患者識別和治療，並改善護理連續性，令人信服。我很高興能加入董事會，支持 Azra 的持續增長和使命。”</p>
</div><p>Azra AI's enterprise platform operationalizes underutilized healthcare data to optimize and orchestrate care and clinical trial pathways — ensuring patients receive immediate, coordinated care within their health system, increasing patient retention and outcomes, and making patient care visible through actionable real-time reporting.</p>
<div class="lb-trans"><p>Azra AI 的企業平台將未充分利用的醫療數據操作化，以優化和編排護理和臨牀試驗路徑——確保患者在其醫療系統內獲得及時、協調的護理，提高患者保留率和結果，並通過可操作的實時報告使患者護理可見。</p>
</div><p>By combining advanced agentic AI, multimodal data integration, and workflow automation, Azra transforms fragmented clinical data into actionable intelligence — powering solutions across lung and breast cancer screening, incidental findings, multidisciplinary meetings, enterprise patient management and care coordination, research and clinical trial matching, ED discharge workflows, and advanced reporting and analytics.</p>
<div class="lb-trans"><p>通過結合先進的代理人工智能、多模態數據集成和工作流程自動化，Azra 將分散的臨牀數據轉化為可操作的智能——為肺癌和乳腺癌篩查、偶發發現、多學科會議、企業患者管理和護理協調、研究和臨牀試驗匹配、急診出院工作流程以及高級報告和分析提供解決方案。</p>
</div><p>The platform's ability to unify these capabilities within a single ecosystem enables health systems to identify patients earlier, coordinate care longitudinally, and eliminate gaps across the continuum. Deployed across hundreds of leading health systems, Azra AI helps reduce time to treatment while driving measurable improvements in patient outcomes, operational efficiency, and ROI at scale.</p>
<div class="lb-trans"><p>該平台在單一生態系統內統一這些能力，使醫療系統能夠更早識別患者，縱向協調護理，並消除整個連續性中的空白。Azra AI 在數百個領先的醫療系統中部署，幫助減少治療時間，同時推動患者結果、運營效率和規模化投資回報的可衡量改善。</p>
</div><p><strong>About Azra AI</strong></p>
<div class="lb-trans"><p><strong>關於 Azra AI</strong></p>
</div><p>Azra AI is a healthcare enterprise platform that operationalizes underutilized data to optimize and orchestrate care and clinical trial pathways — ensuring patients receive immediate, coordinated care within their health system, increasing patient retention and outcomes, and making patient care visible through actionable real-time reporting.</p>
<div class="lb-trans"><p>Azra AI 是一家醫療企業平台，將未充分利用的數據操作化，以優化和編排護理和臨牀試驗路徑——確保患者在其醫療系統內獲得及時、協調的護理，提高患者保留率和結果，並通過可操作的實時報告使患者護理可見。</p>
</div><p>By combining advanced agentic AI, multimodal data integration, and workflow automation, Azra transforms fragmented clinical data into actionable intelligence—powering solutions across lung and breast cancer screening, all incidental findings, multi-disciplinary meetings, enterprise patient management / care coordination, research / clinical trial matching, ED discharge, and robust reporting and analytics.</p>
<div class="lb-trans"><p>通過結合先進的代理人工智能、多模態數據集成和工作流程自動化，Azra 將分散的臨牀數據轉化為可操作的智能——為肺癌和乳腺癌篩查、所有偶發發現、多學科會議、企業患者管理/護理協調、研究/臨牀試驗匹配、急診出院和強大的報告與分析提供解決方案。</p>
</div><p>Azra's ability to unify these capabilities within a single platform enables health systems to identify patients earlier, coordinate care longitudinally, and eliminate gaps across the continuum. Deployed across hundreds of leading health systems, Azra's platform reduces time to treatment, which delivers measurable improvements in patient outcomes, operational efficiency, and ROI at scale.</p>
<div class="lb-trans"><p>Azra 在單一平台內統一這些能力，使醫療系統能夠更早識別患者，縱向協調護理，並消除整個連續性中的空白。Azra 的平台在數百個領先的醫療系統中部署，減少治療時間，從而在患者結果、運營效率和規模化投資回報方面帶來可衡量的改善。</p>
</div><p>Learn more at www.azra-ai.com.</p>
<div class="lb-trans"><p>瞭解更多信息，請訪問 www.azra-ai.com。</p>
</div><p>Media Contact:</p>
<div class="lb-trans"><p>媒體聯繫人：</p>
</div><p>John Marshall</p>
<div class="lb-trans"><p>John Marshall</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>SOURCE Azra AI</p>
<div class="lb-trans"><p>來源：Azra AI</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTE5Jk5ld3NJdGVtSWQ9Q0w2MjExNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTkwOTAzUFJfTkVXU19VU1BSX19fX19DTDYyMTE3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CL62117&amp;Transmission_Id=202605190903PR_NEWS_USPR_____CL62117&amp;DateId=20260519"/></p>

Azra AI 任命腫瘤學領域的領導者 Jessica Turgon 加入董事會